Respiro
Timeline
21 events since 2014Board
Capital
Filings
Financial
Establishments
2014201620182020202220242026
The 2026 accounts are due by 31-07-2027.
2026
Annual accounts 2025 filed NBBmicro format · 43 days before the deadline
2025
Highest result from 2015 to 2025 net €428,177 ▲17.3% The net result of €428,177 is the highest of those years.
Annual accounts 2024 filed PDFmicro format · 20 days before the deadline
Registered in the Peppol Directory Reachable for e-invoices through 0208:0564819221
2024
Liquidity more than 50 times current ratio 64.65 The current ratio rises from 1.27 to 64.65. Short-term debt falls from €576,901 to €8,191.
Annual accounts 2023 filed PDFmicro format · 1 day late
2023
Annual accounts 2022 filed PDFmicro format · 32 days late
2022
Company renamed from Dr. Colin Cordemans, pneumoloog-intensivist to Respiro resigns as director · reappointed as director · “De uitoefening van de geneeskunde door de geneesheer-vennoten, zijnde meer in het bijzonder de…” (deed in Dutch)6 points ▸
- Name change, Respiro
- The capital is divided into 100 shares
- resigns as director
- reappointed as director, not named in the articles
- Discharge granted to
- The registered office is at Nellekenstraat 64, 1750 Lennik
- The deed holds 8 more points.
Annual accounts 2021 filed PDFmicro format · 16 days before the deadline
2021
Annual accounts 2020 filed PDFmicro format · 29 days before the deadline
2020
Annual accounts 2019 filed PDFmicro format · 31 days before the deadline
2019
Liquidity more than 11 times current ratio 59.62 The current ratio rises from 5.10 to 59.62. Short-term debt falls from €142,027 to €12,481.
Annual accounts 2018 filed PDFmicro format · 28 days before the deadline
2018
Equity above €500,000 equity €588,355 ▲24.2% With a profit in every financial year since 2015, equity grows to €588,355.
Annual accounts 2017 filed PDFmicro format · 23 days late
2017
Annual accounts 2016 filed PDFmicro format · 3 days before the deadline
Capital increase of €15,550 to €18,550The capital rose from €3,000 to €18,550 · Legal-form conversion: to private limited company (pre-2019)4 points ▸
- The capital was increased by €15,550
- The capital is €18,550
- Legal-form conversion, to private limited company (pre-2019)
- Power of attorney granted to
- The deed holds 2 more points.
2016
Equity above €200,000 equity €215,942 ▲265% With a profit in every financial year since 2015, equity grows to €215,942.
Annual accounts 2015 filed PDFabbreviated format · 22 days late
2014
IncorporationFounding capital of €3,000, 100 shares · Founded by · appointed as sole manager · published on 21-10-20143 points ▸
- Founded by
- The founding capital is €3,000, divided into 100 shares
- appointed as sole manager
- The deed holds 1 more point.
First establishment Ziekenhuislaan 100, Halle
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
On 17 October 2014, Respiro was incorporated by one private individual, with a starting capital of €3,000.12 A capital increase in 2017 brought the capital to €18,550.3 Since 2022 the company has been called Respiro.4 has served as director since 2014.5 Total assets went from €730,396 in 2018 to €358,029 in 2025.6